Sign Out
Use during Pregnancy, Delivery, or Lactation: This drug should be administered to pregnant or possibly pregnant women only if the anticipated therapeutic benefit is thought to outweigh any potential risk. (The safety of this drug in pregnant women has not been established.)
Nursing should be interrupted when this drug is administered to. (Rat studies have shown that rebamipide is excreted in the breast milk.)
